The Roadmap
Welcome to The Roadmap, the technology law podcast series from Bristows. In this podcast, our technology lawyers dive into the digital transformation trends that are re-shaping modern businesses, even entire industries. In each episode, we will unpack a particular technology or trend – whether a type of transformational project, the latest market practice or a regulatory change – and explain what our clients need to understand in order to add value to their business. If you have any feedback, questions or comments, please email us at theroadmap@bristows.com - we'd love to hear from you. Also, find all the latest episodes on our tech focused site, The Cookie Jar, for views on matters shaping technology: https://www.bristows.com/the-cookie-jar-podcast-videos/
Episodes
AI Governance - Design & Implement
AI governance - Identify & assess
AI Governance – top tips from a technology executive
AI system ‘building blocks’ – a deep dive on value, IP, open v proprietary and legal risks
Medical device software market on the brink? The AI Act alarm bells are ringing - Part 3
Medical device software market on the brink? The AI Act alarm bells are ringing - Part 2
Medical device software market on the brink? The AI Act alarm bells are ringing - Part 1
Navigating the challenges of investing in or acquiring companies utilising Agentic AI
Navigating the Future – Corporate Law and AI – Recognising value in AI transactions
Compliance considerations for consumer tech
NIS2 - Gearing up to the next cybersecurity level
GenAI terms of service benchmarking
AI in the workplace
EU AI Act: Impact on contracts and deals
How to avoid mega tech projects becoming mega tech disputes
EU AI Act: Product safety
EU AI Act – ‘high risk’ AI, roles and requirements
Bonus episode - More signal, less noise: GenAI tools in legal practice
Contractual remedies for customers
Digital Transformation Projects: Getting procurement right
Use of AI and data in the 'Enterprise IT' supply chain
Managing the inevitable – tactics when facing a troubled project
In conversation with AstraZeneca